Somatostatin Market Will Surge at 11.40% CAGR to Reach 460 Million US$ by the End of 2025 QY Research, Inc.
Somatostatin is one kind of hormone. It is widely distributed throughout the body, especially in the hypothalamus and pancreas. It also acts as an important regulator of endocrine and nervous system function by inhibiting the secretion of several other hormones such as growth hormone, insulin, and gastrin.
View full press release